Literature DB >> 29022282

Analysis of five cases of human herpesvirus-6 myelitis among 121 cord blood transplantations.

Toshimitsu Ueki1, Kenichi Hoshi2, Yuki Hiroshima3, Masahiko Sumi3, Naoaki Ichikawa3, Masao Ogata4, Takako Satou4, Takahiro Fukuda5, Hikaru Kobayashi3.   

Abstract

Reports of myelitis associated with human herpesvirus-6 (HHV-6) following allogeneic transplantation are rare. Of 121 cases of cord blood transplantation (CBT) performed at Nagano Red Cross Hospital, five cases (4.1%) of HHV-6 myelitis developed at around the time of engraftment. The major symptom identified in all five patients was superficial pain or pruritus linked to segmental levels of the spinal cord. Other identified symptoms were fever or low-grade fever in all five patients, autonomic nerve disorder in four patients, bladder and rectal disturbance in two patients, and extrapyramidal disorder in two patients. These symptoms were experienced primarily 16-39 days after CBT. HHV-6 PCR tests were all positive for cerebrospinal fluid and for plasma. Of the four cases tested by magnetic resonance imaging (MRI), three showed spinal cord abnormality. Antiviral therapy using foscarnet or ganciclovir was effective in every case. Although one case treated from 12 days after onset experienced long-term pain resembling postherpetic neuralgia, symptoms in the four cases were completely relieved after antiviral therapy. In summary, the major symptoms of HHV-6 myelitis were superficial pain linked to segmental levels of the spinal cord. Prognosis may be improved by early initiation of antiviral therapy.

Entities:  

Keywords:  Cord blood transplantation; Human herpesvirus-6; Myelitis; Pain; Pre-engraftment immune reaction

Mesh:

Substances:

Year:  2017        PMID: 29022282     DOI: 10.1007/s12185-017-2347-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  40 in total

1.  Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.

Authors:  Akiko Yamane; Takehiko Mori; Shigeaki Suzuki; Ai Mihara; Rie Yamazaki; Yoshinobu Aisa; Tomonori Nakazato; Takayuki Shimizu; Yasuo Ikeda; Shinichiro Okamoto
Journal:  Biol Blood Marrow Transplant       Date:  2007-01       Impact factor: 5.742

2.  Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Katsumichi Fujimaki; Takehiko Mori; Aiko Kida; Masatsugu Tanaka; Nobutaka Kawai; Takafumi Matsushima; Kenji Kishi; Shin Fujisawa; Tohru Sakura; Akira Yokota; Yoshinobu Kanda; Jun Taguchi; Hideki Akiyama; Heiwa Kanamori; Atsuo Maruta; Shinichiro Okamoto; Hisashi Sakamaki
Journal:  Int J Hematol       Date:  2006-12       Impact factor: 2.490

3.  Human herpesvirus 6 in salivary glands.

Authors:  J D Fox; M Briggs; P A Ward; R S Tedder
Journal:  Lancet       Date:  1990-09-08       Impact factor: 79.321

4.  [Acute lymphoblastic leukemia presenting with calcineurin-inhibitor induced pain syndrome after a second allogeneic bone marrow transplantation].

Authors:  Shuichiro Takashima; Akihiko Numata; Toshihiro Miyamoto; Tsuyoshi Shirakawa; Rieko Kinoshita; Kouji Kato; Katsuto Takenaka; Naoki Harada; Koji Nagafuji; Shuichi Taniguchi; Mine Harada
Journal:  Rinsho Ketsueki       Date:  2006-10

5.  Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections.

Authors:  D Donati; N Akhyani; A Fogdell-Hahn; C Cermelli; R Cassiani-Ingoni; A Vortmeyer; J D Heiss; P Cogen; W D Gaillard; S Sato; W H Theodore; S Jacobson
Journal:  Neurology       Date:  2003-11-25       Impact factor: 9.910

6.  Ketamine inhibits glutamate-, N-methyl-D-aspartate-, and quisqualate-stimulated cGMP production in cultured cerebral neurons.

Authors:  J M Gonzales; A L Loeb; P S Reichard; S Irvine
Journal:  Anesthesiology       Date:  1995-01       Impact factor: 7.892

7.  Calcineurin-inhibitor-induced pain syndrome after bone marrow transplantation.

Authors:  Yukiko Noda; Kenji Kodama; Tetsujiro Yasuda; Shosuke Takahashi
Journal:  J Anesth       Date:  2008-02-27       Impact factor: 2.078

8.  Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study.

Authors:  Masao Ogata; Takako Satou; Jun-ichi Kadota; Noriyuki Saito; Takashi Yoshida; Hirokazu Okumura; Toshimitsu Ueki; Koji Nagafuji; Shinichi Kako; Nobuhiko Uoshima; Mitsuru Tsudo; Hidekazu Itamura; Takahiro Fukuda
Journal:  Clin Infect Dis       Date:  2013-05-30       Impact factor: 9.079

9.  Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.

Authors:  Joshua A Hill; Sophia Koo; Belisa B Guzman Suarez; Vincent T Ho; Corey Cutler; John Koreth; Philippe Armand; Edwin P Alyea; Lindsey R Baden; Joseph H Antin; Robert J Soiffer; Francisco M Marty
Journal:  Biol Blood Marrow Transplant       Date:  2012-05-04       Impact factor: 5.742

10.  Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients.

Authors:  M Ogata; T Satou; R Kawano; S Takakura; K Goto; J Ikewaki; K Kohno; T Ikebe; T Ando; Y Miyazaki; E Ohtsuka; Y Saburi; T Saikawa; J Kadota
Journal:  Bone Marrow Transplant       Date:  2009-05-25       Impact factor: 5.483

View more
  3 in total

1.  Comparison of HHV-6 DNA detection in plasma and whole blood in allogeneic hematopoietic stem cell transplant recipients: frequent false-positive results for active HHV-6 infection using whole blood samples.

Authors:  Kuniko Takano; Masao Ogata; Rie Kawano; Takako Satou; Yuko Nashimoto; Kuniaki Shirao
Journal:  Int J Hematol       Date:  2018-07-16       Impact factor: 2.490

2.  Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation.

Authors:  Katherine N Ward; Joshua A Hill; Petr Hubacek; Rafael de la Camara; Roberto Crocchiolo; Hermann Einsele; David Navarro; Christine Robin; Catherine Cordonnier; Per Ljungman
Journal:  Haematologica       Date:  2019-08-29       Impact factor: 9.941

3.  HHV-6: an unusual cause of cerebellar ataxia.

Authors:  Emad Abu Sitta; Ana Khazan; Kelly Luttmann; Jennifer Hanrahan
Journal:  BMJ Case Rep       Date:  2020-03-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.